Yuichi Horigome

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma.

Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma.

Journal: IDCases

Published: July 21, 2026

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability.

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability.

Journal: Blood research

Published: June 17, 2026

Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia

Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 04, 2026

Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment.

Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment.

Journal: International journal of hematology

Published: January 03, 2026

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

Journal: American journal of hematology

Published: March 10, 2025

Incidence of herpes zoster in transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone.

Incidence of herpes zoster in transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone.

Journal: International journal of hematology

Published: November 19, 2024

Daratumumab Treatment for "Truly Frail" Elderly Myeloma Patients.

Daratumumab Treatment for "Truly Frail" Elderly Myeloma Patients.

Journal: Life (Basel, Switzerland)

Published: February 13, 2024

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Journal: Blood

Published: October 25, 2023

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

Journal: Annals of hematology

Published: April 06, 2023

Successful treatment of non-AIDS Kaposi's sarcoma with eribulin.

Successful treatment of non-AIDS Kaposi's sarcoma with eribulin.

Journal: The Journal of dermatology

Published: March 05, 2021

Acute leukemia developing in the second trimester of pregnancy

Acute leukemia developing in the second trimester of pregnancy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 10, 2020

Coagulation disorder

Coagulation disorder

Journal: Nihon rinsho. Japanese journal of clinical medicine

Published: November 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026